Drug Type Small molecule drug |
Synonyms GDC-6988, RG6421 |
Target |
Mechanism ANO1 stimulants(anoctamin 1 stimulants) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-cystic fibrosis bronchiectasis | Phase 2 | US | 18 Nov 2024 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | US | 18 Nov 2024 | |
Cystic Fibrosis | Phase 1 | US | 24 May 2023 |